FREE Immunoprofile for Feline Lymphoma & Leukemia Patients

We provide flow cytometry and PARR results for participating in our feline lymphoma study.

A cute cat, looking up with curious look

Brief Summary &
Expected Outcome

Currently Enrolling (Last Update: May 2022)

    ImpriMed is seeking clinical research partners to develop our feline drug response predictions.

    Benefits per case

    benefits to doctor/clinic

    • Free Flow Cytometry and PARR for each feline patient with suspected neoplasia
    • Virtual Educational Meetings on immunophenotyping

    Benefits to Staff/Techs

    • $10 Amazon e-gift card for each patient’s set of samples we receive with their assistance

    Patient type

    We are requesting the samples from:

    Feline patients with suspected neoplasia

    Sample requirements

    For each patient, we request all of the following:

    2ml whole blood in an EDTA tube
    Fine needle aspirates of the affected organ put into our proprietary media transport tubes and overnighted to our lab
    One air-dried slide with cells from FNA (for PARR testing)

    Sample Submission

    If you have not already, please register for access to our Vet Portal by clicking HERE. At the top of the page, hover over ‘Samples’ -> Select ‘Sample Submission’ from the drop-down -> Select ‘New Patient Sample’.

    Please read the instructions on our Vet Portal for FNA collection guide carefully to ensure you collect enough cells for the FNA. Please ensure all participating pet owners sign the consent form to allow us to use their cat’s sample for research.

    For Felines Participation

    • Select Feline Pilot Research (free choice).
    • Under the “Diagnostic Results” comment box, please note the number of air-dried cytology slides, FNA in our media tubes and EDTA tubes.
    • Note: Volunteers will not be charged and ImpriMed will reach out to the email address registered on the portal to process the compensation.

    Why Participate?

    One of the many benefits of AI-led diagnostics like ImpriMed is the ability to be constantly developing and improving based on the clinical outcomes of existing cases. This approach to the evolution of the assay improves the accuracy and applicability for all returning and future patients.

    We will be reaching out to all clients 3-5 months after sampling to request data on which treatment courses were ultimately used and how the patient responded to compare how closely the predictions aligned with the clinical outcomes. For each patient’s clinical outcome report, we will offer a $10 Amazon e-gift card to the team for their assistance.

    A female scientist conducting an experiment in a lab setting

    Sign up Here

    To get started, fill out the form and we will send you our proprietary transport media tubes to your clinic.

    A cat directly looking straight